Pharmacological and clinical differences between low-molecular-weight heparins: implications for prescribing practice and therapeutic interchange.
Publication/Presentation Date
2-1-2010
Abstract
Thanks to their predictable pharmacokinetics and ease of use, low-molecular-weight heparins (LMWHs) have established uses in the prevention and treatment of thrombotic diseases and as a replacement for unfractionated heparin (UFH). Although LMWHs as a class have similar antithrombotic effects, they comprise a diverse group of agents with distinct biochemical and pharmacological profiles. In light of the ongoing pressure to contain pharmacy costs, the diversity among the LMWHs and their benefits over UFH are important considerations in clinical practice.
Volume
35
Issue
2
First Page
95
Last Page
105
ISSN
1052-1372
Published In/Presented At
Merli, G. J., & Groce, J. B. (2010). Pharmacological and clinical differences between low-molecular-weight heparins: implications for prescribing practice and therapeutic interchange. P & T : a peer-reviewed journal for formulary management, 35(2), 95–105.
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
20221326
Department(s)
Administration and Leadership
Document Type
Article